PLEGRIDY

Product Overview

About PLEGRIDY

Plegridy is a prescription medication used to treat relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. It is an interferon beta-1a injection that helps reduce the frequency of MS relapses and slow the progression of physical disability.

Key Benefits & Uses

• Treatment of relapsing forms of multiple sclerosis (MS)
• Reduction of MS relapse frequency
• Slowing of physical disability progression in MS patients

Active Ingredient & Action

Plegridy contains the active ingredient peginterferon beta-1a, a recombinant form of human interferon beta-1a. Peginterferon beta-1a works by modulating the immune system's response to the central nervous system, reducing inflammation and preventing damage to the myelin sheath that surrounds nerve fibers.

Important Notes

Plegridy is administered via injection every 28 days. It is essential to follow the recommended dosing schedule and consult with a healthcare professional for proper administration and monitoring. Common side effects may include injection site reactions, flu-like symptoms, and liver enzyme elevations. Patients with a history of depression, anxiety, or other psychiatric conditions should be closely monitored while taking Plegridy.